Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

about

FSD-C10 Shows Therapeutic Effects in Suppressing oxidized low-density lipoprotein (ox-LDL)-Induced Human Brain Microvascular Endothelial Cells Apoptosis via Rho-Associated Coiled-Coil Kinase (ROCK)/Mitogen-Activated Protein Kinase (MAPK) Signaling

P2860

Q58795391-4CCC7E0B-54EB-4ED7-9038-2A328CA71F79

P2860

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

Item

http://www.wikidata.org/entity/Q47199486

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Haemoglobin glycation index an ...... ed Evaluation (ADVANCE) trial.

@en

Haemoglobin glycation index an ...... Release Controlled Evaluation

@nl

type

Item

label

Haemoglobin glycation index an ...... ed Evaluation (ADVANCE) trial.

@en

Haemoglobin glycation index an ...... Release Controlled Evaluation

@nl

prefLabel

Haemoglobin glycation index an ...... ed Evaluation (ADVANCE) trial.

@en

Haemoglobin glycation index an ...... Release Controlled Evaluation

@nl

P1476

Haemoglobin glycation index an ...... ed Evaluation (ADVANCE) trial.

@en

P2093

ADVANCE Collaborative Group

http://www.w3.org/2001/XMLSchema#string

Bryan Williams

http://www.w3.org/2001/XMLSchema#string

J Hans DeVries

http://www.w3.org/2001/XMLSchema#string

John Chalmers

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Mark Woodward

http://www.w3.org/2001/XMLSchema#string

Michel Marre

http://www.w3.org/2001/XMLSchema#string

Qiang Li

http://www.w3.org/2001/XMLSchema#string

Sigrid C van Steen

http://www.w3.org/2001/XMLSchema#string

Stephen Colagiuri

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effects of intensive glucose lowering in type 2 diabetes

Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial.

Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes.

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial

Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

P2888

s00125-017-4539-1

P304

780-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-017-4539-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Mancia

Pavel Hamet

Diederick E Grobbee

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29308539

http://www.w3.org/2001/XMLSchema#string

P932

6448976

http://www.w3.org/2001/XMLSchema#string

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

about

P2860

P2860

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932